953421-72-2 Usage
Uses
Used in Pharmaceutical Industry:
4-Bromo-7-chloroisoquinoline is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique structural properties allow for the creation of diverse chemical entities with potential medicinal applications.
Used in Agrochemical Industry:
In the agrochemical industry, 4-bromo-7-chloroisoquinoline serves as an intermediate in the synthesis of various agrochemicals, including pesticides and herbicides. Its presence in these compounds can enhance their effectiveness in controlling pests and weeds, thereby improving crop yields and quality.
Used in Medicinal Chemistry and Drug Discovery:
4-Bromo-7-chloroisoquinoline is utilized as a key building block in medicinal chemistry and drug discovery, where its unique structural properties can be exploited to design and develop novel therapeutic agents. Its potential applications in this field highlight the importance of exploring and understanding the properties of such chemical compounds for the advancement of medical science.
Check Digit Verification of cas no
The CAS Registry Mumber 953421-72-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,3,4,2 and 1 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 953421-72:
(8*9)+(7*5)+(6*3)+(5*4)+(4*2)+(3*1)+(2*7)+(1*2)=172
172 % 10 = 2
So 953421-72-2 is a valid CAS Registry Number.
953421-72-2Relevant academic research and scientific papers
MDM2 DEGRADERS AND USES THEREOF
-
Paragraph 002058; 002059-002060, (2021/09/26)
The present invention relates to compounds and methods useful for the modulation of mouse double minute 2 homolog ("MDM2") protein via ubiquitination and/or degradation by compounds according to the present invention.
Inhibitors of checkpoint kinases
-
Page/Page column 29; 30, (2008/06/13)
The instant invention provides for compounds which comprise substituted triazoloquinazolinones that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by adminis
